An open, randomized, controlled, multicenter study to assess the change in time to onset of 1-mm-ST-segment depression produced by carvedilol (Dilatrend) versus metoprolol in patients with chronic stable angina pectoris.

Trial Profile

An open, randomized, controlled, multicenter study to assess the change in time to onset of 1-mm-ST-segment depression produced by carvedilol (Dilatrend) versus metoprolol in patients with chronic stable angina pectoris.

Completed
Phase of Trial: Phase III

Latest Information Update: 26 Feb 2010

At a glance

  • Drugs Carvedilol; Metoprolol
  • Indications Angina pectoris
  • Focus Therapeutic Use
  • Sponsors Shanghai Roche Pharmaceuticals
  • Most Recent Events

    • 26 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top